Company Active LTD

Company profile

Blackford Analysis Limited

Bot Verification

Blackford Analysis Limited is a UK company with status active founded in 2010 based in Scotland.

CRN
SC380297
Founded
2010
Age
16

Overview

Legal name
BLACKFORD ANALYSIS LIMITED
Region
Scotland
Registered address
160 CAUSEWAYSIDE
EDINBURGH
SCOTLAND
EH9 1PR
Insolvency history
No

Corporate ownership

Updated 06 Jun 2026 16:52

2 levels 2 ultimate controllers Controls 1
1
Company Active LTD
Blackford Analysis Limited
CRN SC380297
2
Direct controller Active PLC
3
Ultimate controller
51490986
CRN 51490986
4
Ultimate controller
HRB 48248
CRN HRB 48248

Company events

Reference milestones and recent Companies House filing stream events.

10 events
30 Sep
2026

Accounts due

Accounts Due

Next accounts due date

28 Jun
2026

Confirmation statement due

Confirmation Due

Next confirmation statement due date

26 May
2026

Legacy

Miscellaneous

ANNOTATION | Transaction MzUyMzY3MDkzNGFkaXF6a2N4 | Paper/PDF filed

Published 26 May 2026 12:10

11 May
2026

Termination Director Company With Name Termination Date

Officers

TM01 | Transaction MzUyMDY4NzkzN2FkaXF6a2N4

Published 26 May 2026 12:08

14 Jun
2025

Confirmation statement filed

Confirmation

Last confirmation statement made up date

31 Dec
2024

Accounts filed

Accounts

Last accounts made up date

21 Nov
2024

Appoint Corporate Secretary Company With Name Date

Officers

AP04 | Transaction MzQ0NDQ2MDMwM2FkaXF6a2N4

Published 21 Nov 2024 04:25

21 Nov
2024

Termination Secretary Company With Name Termination Date

Officers

TM02 | Transaction MzQ0NDQ1OTgxMWFkaXF6a2N4

Published 21 Nov 2024 04:20

10 Sep
2024

Accounts With Accounts Type Small

Accounts PDF pending

AA | Transaction MzQzNTA1MTc4MGFkaXF6a2N4 | Paper/PDF filed

Published 11 Sep 2024 06:12

14 Jun
2010

Incorporated

Inception

Company registered at Companies House

Public funding

1 award
First funded
2016
Funded years
2016
Age at first award
5 years

Projects

2016 GRD Development of Prototype Lead participant

Prototype Lesion Tracking Clinical Workflow and Vendor Neutral Pre-Processing Platform for Medical Imaging

1 Apr 2016 to 31 Jul 2017

Awarded
£238,373
Total cost £529,718

50% of the UK population born after 1960 will be diagnosed with some form of cancer during their lifetime. Medical imaging is used for diagnosis in 60% of all patient care episodes and plays a vital role in almost all cancer diagnosis, monitoring and treatment. The use of imaging throughout the care chain, specifically in oncology, has increased dramatica...

Product types

GRD Development of Prototype